Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin - PubMed (original) (raw)
Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin
C Betsholtz et al. Proc Natl Acad Sci U S A. 1986 Sep.
Abstract
Simian sarcoma virus, an acutely transforming primate retrovirus with capacity to induce gliomas and sarcomas in experimental animals, has acquired its transforming properties by transducing the cellular gene sequences that encode one of the constituent chains of platelet-derived growth factor. Suramin, a drug used in the treatment of trypanosomiasis and onchocerciasis, has previously been reported to inhibit the interaction of platelet-derived growth factor with its cell surface receptor. We show here that suramin efficiently reverts the simian sarcoma virus-induced transformed phenotype in human and rat fibroblasts and propose that this is due to neutralization of an externalized v-sis product. Moreover, we show that suramin inhibits the action of a broad spectrum of growth factors.
Similar articles
- The phenotypic characteristics of simian sarcoma virus-transformed human fibroblasts suggest that the v-sis gene product acts solely as a PDGF receptor agonist in cell transformation.
Johnsson A, Betsholtz C, Heldin CH, Westermark B. Johnsson A, et al. EMBO J. 1986 Jul;5(7):1535-41. doi: 10.1002/j.1460-2075.1986.tb04394.x. EMBO J. 1986. PMID: 3017700 Free PMC article. - Platelet-derived growth factor: roles in normal and v-sis transformed cells.
Deuel TF, Kimura A, Maehama S, Tong BD. Deuel TF, et al. Cancer Surv. 1985;4(4):633-53. Cancer Surv. 1985. PMID: 2824043 Review. - [Epidermal growth factor: structure, location, phosphorylation and regulation of its receptor].
St-Arnaud R, Chabot JG, Pelletier G, Labrie F, Walker P. St-Arnaud R, et al. Biochimie. 1984 Jul-Aug;66(7-8):515-30. doi: 10.1016/0300-9084(84)90146-9. Biochimie. 1984. PMID: 6099148 Review. French.
Cited by
- Delivery of platelet-derived growth factor as a chemotactic factor for mesenchymal stem cells by bone-mimetic electrospun scaffolds.
Phipps MC, Xu Y, Bellis SL. Phipps MC, et al. PLoS One. 2012;7(7):e40831. doi: 10.1371/journal.pone.0040831. Epub 2012 Jul 12. PLoS One. 2012. PMID: 22808271 Free PMC article. - The follicle-stimulating hormone receptor: a novel target in genitourinary malignancies.
Gartrell BA, Tsao CK, Galsky MD. Gartrell BA, et al. Urol Oncol. 2013 Nov;31(8):1403-7. doi: 10.1016/j.urolonc.2012.03.005. Epub 2012 Apr 17. Urol Oncol. 2013. PMID: 22513137 Free PMC article. Review. - Autocrine PDGF stimulation in malignancies.
Heldin CH. Heldin CH. Ups J Med Sci. 2012 May;117(2):83-91. doi: 10.3109/03009734.2012.658119. Ups J Med Sci. 2012. PMID: 22512244 Free PMC article. Review. - Safety of recombinant human platelet-derived growth factor-BB in Augment(®) Bone Graft.
Solchaga LA, Hee CK, Roach S, Snel LB. Solchaga LA, et al. J Tissue Eng. 2012;3(1):2041731412442668. doi: 10.1177/2041731412442668. Epub 2012 Apr 4. J Tissue Eng. 2012. PMID: 22511993 Free PMC article. - Ferric cacodylate efficiently stimulates growth of rat renal glomerular epithelial cells in vitro.
Yamada M, Moritoh C, Okigaki T. Yamada M, et al. Cytotechnology. 1990 May;3(3):245-51. doi: 10.1007/BF00365488. Cytotechnology. 1990. PMID: 22358774
References
- J Natl Cancer Inst. 1971 Oct;47(4):881-9 - PubMed
- J Cell Biochem. 1985;29(3):265-73 - PubMed
- In Vitro. 1977 Jul;13(7):399-416 - PubMed
- Adv Pharmacol Chemother. 1978;15:289-322 - PubMed
- Cancer Lett. 1979 Nov;8(1):9-22 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials